Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric R Bates

Showing results (51-60 of 234) with videos related to

Pageof 24
Sort By:
Annals of Internal Medicine|February 25, 2009
ACP Journal Club. Review: Sgarbossa scores > or = 3 have low sensitivity and high specificity for predicting MI in left bundle branch blockEric R Bates
Evidence-Based Medicine|October 7, 2008
Review: limited evidence suggests that statins are safe in patients with liver diseaseEric R Bates
JACC. Cardiovascular Interventions|May 26, 2009
Aspirating and filtering atherothrombotic debris during percutaneous coronary interventionEric R Bates
American Heart Journal|October 12, 2010
The role of the electrocardiogram as a prognostic tool in ST-segment elevation myocardial infarctionEric R Bates
Polskie Archiwum Medycyny Wewnetrznej|May 15, 2008
2007 focused update of the ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarctionEric R Bates
Annals of Internal Medicine|February 28, 2017
In left main CAD, PCI with everolimus-eluting stents was noninferior to CABG for death, MI, or stroke at 3 yearsEric R Bates
Circulation. Cardiovascular Interventions|April 14, 2020
Stent-Centric View of Stable Ischemic Heart DiseaseEric R Bates
JACC. Cardiovascular Interventions|February 15, 2023
What Is a Periprocedural Major Adverse Event After PCI and CABG?Eric R Bates
JACC. Cardiovascular Interventions|October 20, 2012
Weighing the risks of target vessel revascularization versus very late stent thrombosis in primary percutaneous coronary interventionEric R Bates
Annals of Internal Medicine|December 1, 2025
After successful PCI for AMI and 1 mo of DAPT, P2Y12 inhibitor monotherapy was noninferior to continued DAPT for adverse outcomesEric R Bates,
Pageof 24

Showing results (51-60 of 234) with videos related to

Sort By:
Pageof 24
Annals of Internal Medicine|February 25, 2009
ACP Journal Club. Review: Sgarbossa scores > or = 3 have low sensitivity and high specificity for predicting MI in left bundle branch blockEric R Bates
Evidence-Based Medicine|October 7, 2008
Review: limited evidence suggests that statins are safe in patients with liver diseaseEric R Bates
JACC. Cardiovascular Interventions|May 26, 2009
Aspirating and filtering atherothrombotic debris during percutaneous coronary interventionEric R Bates
American Heart Journal|October 12, 2010
The role of the electrocardiogram as a prognostic tool in ST-segment elevation myocardial infarctionEric R Bates
Polskie Archiwum Medycyny Wewnetrznej|May 15, 2008
2007 focused update of the ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarctionEric R Bates
Annals of Internal Medicine|February 28, 2017
In left main CAD, PCI with everolimus-eluting stents was noninferior to CABG for death, MI, or stroke at 3 yearsEric R Bates
Circulation. Cardiovascular Interventions|April 14, 2020
Stent-Centric View of Stable Ischemic Heart DiseaseEric R Bates
JACC. Cardiovascular Interventions|February 15, 2023
What Is a Periprocedural Major Adverse Event After PCI and CABG?Eric R Bates
JACC. Cardiovascular Interventions|October 20, 2012
Weighing the risks of target vessel revascularization versus very late stent thrombosis in primary percutaneous coronary interventionEric R Bates
Annals of Internal Medicine|December 1, 2025
After successful PCI for AMI and 1 mo of DAPT, P2Y12 inhibitor monotherapy was noninferior to continued DAPT for adverse outcomesEric R Bates,
Pageof 24